meglumine has been researched along with Glioblastoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Black, KL; Ding, H; Galstyan, A; Grodzinski, ZB; Holler, E; Israel, LL; Ljubimova, JY; Patil, R; Shatalova, ES; Wagner, S | 1 |
| Hedderich, D; Kirschke, JS; Kluge, A; Preibisch, C; Pyka, T; Wiestler, B; Zimmer, C | 1 |
| Akbari, H; Bilello, M; Da, X; Davatzikos, C; Macyszyn, L; O'Rourke, DM; Verma, R; Wolf, RL | 1 |
| Bendszus, M; Bonekamp, D; Deike, K; Heiland, S; Radbruch, A; Wick, W; Wiestler, B | 1 |
| Engelholm, SA; Larsson, HB; Law, I; Lundemann, M; Møller, S; Poulsen, HS | 1 |
| Bendszus, M; Bonekamp, D; Burth, S; Heiland, S; Kickingereder, P; Radbruch, A; Schlemmer, HP; Wick, A; Wick, W | 1 |
| Bendszus, M; Bonekamp, D; Burth, S; Eidel, O; Götz, M; Kickingereder, P; Maier-Hein, KH; Radbruch, A; Schlemmer, HP; Wick, A; Wick, W | 1 |
| Choi, CG; Kim, C; Kim, HS; Kim, JH; Kim, SJ; Shim, WH | 1 |
| Grabner, G; Hoeftberger, R; Knosp, E; Noebauer-Huhmann, IM; Pinker, K; Stadlbauer, A; Stavrou, I; Szomolanyi, P; Trattnig, S; Weber, M | 1 |
| Bozzao, A; Fantozzi, LM; Fasoli, F; Ferrante, L; Ferrante, M; Romano, A | 1 |
| Kurki, T; Niemi, P; Valtonen, S | 1 |
| Bryce, R; Etienne, MC; Ferrero, JM; Fischel, JL; Formento, P; Ilc, K; Milano, G | 1 |
| Donovan, M; Parker, JR; Runge, VM | 1 |
1 trial(s) available for meglumine and Glioblastoma
| Article | Year |
|---|---|
Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
Topics: Brain Neoplasms; Chelating Agents; Contrast Media; Corpus Callosum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2002 |
12 other study(ies) available for meglumine and Glioblastoma
| Article | Year |
|---|---|
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice, Nude; Nanostructures; Organometallic Compounds; Xenograft Model Antitumor Assays | 2020 |
Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
Topics: Algorithms; Brain Neoplasms; Cerebral Blood Volume; Contrast Media; Female; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results | 2019 |
Pattern analysis of dynamic susceptibility contrast-enhanced MR imaging demonstrates peritumoral tissue heterogeneity.
Topics: Brain Neoplasms; Contrast Media; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neoplasm Recurrence, Local; Organometallic Compounds; Pattern Recognition, Automated; Principal Component Analysis; Retrospective Studies | 2014 |
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Computer Simulation; Contrast Media; Female; Germany; Glioblastoma; Humans; Image Enhancement; Imaging, Three-Dimensional; Incidence; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis | 2015 |
Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging.
Topics: Brain Neoplasms; Contrast Media; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies; Radiotherapy, Intensity-Modulated | 2015 |
MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Female; Glioblastoma; Hemodynamics; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Organometallic Compounds; Prognosis; Retrospective Studies; Survival Rate | 2016 |
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
Topics: Brain Neoplasms; Contrast Media; Female; Germany; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Survival Rate; Tumor Burden | 2016 |
Recurrent Glioblastoma: Combination of High Cerebral Blood Flow with MGMT Promoter Methylation Is Associated with Benefit from Low-Dose Temozolomide Rechallenge at First Recurrence.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Combined Modality Therapy; Contrast Media; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Organometallic Compounds; Polymerase Chain Reaction; Retrospective Studies; Temozolomide; Treatment Outcome | 2017 |
High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Efficiency; Ependymoma; Female; Glioblastoma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Oligodendroglioma; Organometallic Compounds; Plasmacytoma; Sensitivity and Specificity | 2008 |
Fiber density index, fractional anisotropy, adc and clinical motor findings in the white matter of patients with glioblastoma.
Topics: Adult; Aged; Anisotropy; Brain; Brain Mapping; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Functional Laterality; Glioblastoma; Humans; Image Enhancement; Male; Meglumine; Middle Aged; Nerve Fibers; Observer Variation; Organometallic Compounds; Paresis; Pyramidal Tracts; Reproducibility of Results | 2008 |
MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
Topics: Astrocytoma; Brain; Brain Edema; Brain Neoplasms; Contrast Media; Diagnostic Errors; Drug Combinations; Gadolinium DTPA; Glioblastoma; Humans; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Organometallic Compounds; Pentetic Acid | 1994 |
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Drug Interactions; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Glioblastoma; Humans; Lithium Compounds; Meglumine; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured | 1999 |